Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Latest News
    • Reduced exposure to...

    Reduced exposure to flame retardants necessary for increased success rate of IVF

    Written by Anjali Nimesh Nimesh Published On 2017-08-25T09:10:58+05:30  |  Updated On 25 Aug 2017 9:10 AM IST
    Reduced exposure to flame retardants necessary for increased success rate of IVF

    Women with higher urinary concentrations of a common type of flame retardant had reduced likelihood of clinical pregnancy and live birth than those with lower concentrations, according to researchers at Harvard T.H. Chan School of Public Health. The study, conducted in the Fertility Clinic at Massachusetts General Hospital, is the first to examine associations between organophosphate flame retardants (PFRs) which are used in polyurethane foam in many products, including upholstered furniture, baby products, and gym mats and reproductive outcomes in women.


    "These findings suggest that exposure to PFRs may be one of many risk factors for lower reproductive success," said first author Courtney Carignan, a research fellow in the Department of Environmental Health at Harvard Chan School. "They also add to the body of evidence indicating a need to reduce the use of these flame retardants and identify safer alternatives."


    The study will be published online August 25, 2017 in Environmental Health Perspectives.


    One in six couples struggles with infertility--a proportion likely to rise as increasing numbers of people in developed countries delay childbearing. Previous studies have linked exposure to products containing hormone-disrupting chemicals, such as pesticides and phthalates, to infertility and poorer reproductive success.


    The flame retardant PentaBDE, used in polyurethane foam, was phased out more than a decade ago after it was linked with negative health effects in animal and epidemiologic studies. PFRs were introduced as a safer alternative, but they have been found in animal studies to cause hormone disruption. Studies have also shown that PFRs can migrate out of furniture and other products into the air and dust of indoor environments.


    For this study, the researchers analyzed urine samples from 211 women undergoing in vitro fertilization (IVF) at the Massachusetts General Hospital Fertility Center between 2005 and 2015. The women were enrolled in the Environment and Reproductive Health (EARTH) study, which looks at how environmental chemicals and lifestyle choices affect reproductive health. The statistical analysis took into consideration factors including maternal age and race, smoking history, and body mass index (BMI).


    The researchers found that the urinary metabolites (products of a chemical that has been metabolized) of three PFRs-- TDCIPP, TPHP, and mono-ITP--were detected in more than 80% of participants. On average, compared to women with lower concentrations of these metabolites, women with higher concentrations had a 10% reduced probability of successful fertilization, 31% reduced probability of implantation of the embryo, and a 41% and 38% decrease in clinical pregnancy (fetal heartbeat confirmed by ultrasound) and live birth.


    "Couples undergoing IVF and trying to improve their chances of success by reducing their exposure to environmental chemicals may want to opt for products that are flame-retardant free," said senior author Russ Hauser, Frederick Lee Hisaw professor of reproductive physiology and acting chair, Department of Environmental Health.


    Further research is needed on the potential impact of male partners' exposure to flame retardant chemicals and on the joint effects on both men and women of exposure to different types of environmental chemicals, the researchers said.

    body mass indexCourtney Carignanfertility treatmentsFlame retardantsin-vitro fertilizationIVFlower concentrationsMassachusetts General Hospitalorganophosphate flame retardantsPregnancyRuss Hauserurinary concentrations

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Anjali Nimesh Nimesh
    Anjali Nimesh Nimesh
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok